AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Discover how the synergy between AI and cell-free systems is driving a new era in biopharma innovation, accelerating drug ...

The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...

An Oxford company which uses AI to develop cancer treatments has achieved further validation for its approach to tackling multiple tumours. Oxford Drug Design's colorectal cancer model study on mice ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...